30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
IL Biotechnology & Medical Research

Neurosense Therapeutics Ltd (NRSN)

Track

In the last 90 days, Neurosense Therapeutics Ltd. saw two insider buy transactions totaling $400,000. Both the CEO and CFO made significant purchases on June 16, 2026, each acquiring 250,000 shares for $200,000. This activity occurred against a backdrop of a 6.4% stock price decrease over the past 90 days.
Stock chart
Ticker: NRSN Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Eisenberg Or
Chief Financial Officer
1 purchase — total 100,000 USD
Buy 16 Jun 2026
Value US$358,141.27 | Price 424.69 | Shares 67,984
Buy 16 Jun 2026
Value US$4,708,347.91 | Price 185.21 | Shares 93,481
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-06-17 2026-06-16 B Purchase
Eisenberg Or

Chief Financial Officer

Officer
67,984 -42.2%
424.69
US$358,141 		67,984 -42.2% 424.69 US$358,141
2026-06-17 2026-06-16 B Purchase
Ben-Noon Alon

Chief Executive Officer

Officer
93,481 -14.5%
185.21
US$4,708,348 		93,481 -14.5% 185.21 US$4,708,348
Explore more

More insider trading research around Neurosense Therapeutics Ltd

More insider trades in IL
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity